Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice.

MLA

Marrero-Rosado, Brenda M., et al. “Ketamine as Adjunct to Midazolam Treatment Following Soman-Induced Status Epilepticus Reduces Seizure Severity, Epileptogenesis, and Brain Pathology in Plasma Carboxylesterase Knockout Mice.” Epilepsy & Behavior : E&B, vol. 111, Oct. 2020, p. 107229. EBSCOhost, https://doi.org/10.1016/j.yebeh.2020.107229.

APA

Marrero-Rosado, B. M., de Araujo Furtado, M., Kundrick, E. R., Walker, K. A., Stone, M. F., Schultz, C. R., Nguyen, D. A., & Lumley, L. A. (2020). Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice. Epilepsy & Behavior : E&B, 111, 107229. https://doi.org/10.1016/j.yebeh.2020.107229

Chicago

Marrero-Rosado, Brenda M, Marcio de Araujo Furtado, Erica R Kundrick, Katie A Walker, Michael F Stone, Caroline R Schultz, Donna A Nguyen, and Lucille A Lumley. 2020. “Ketamine as Adjunct to Midazolam Treatment Following Soman-Induced Status Epilepticus Reduces Seizure Severity, Epileptogenesis, and Brain Pathology in Plasma Carboxylesterase Knockout Mice.” Epilepsy & Behavior : E&B 111 (October): 107229. doi:10.1016/j.yebeh.2020.107229.